Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III ... - MarketWatch (press release)

Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III ... MarketWatch (press release) For the primary endpoint, the Young Mania Rating Scale (YMRS), the data showed that cariprazine treated patients with acute manic episodes experienced significant improvements in symptoms compared to placebo-treated patients observed as early as day ... FOREST LABORATORIES, INC. : and Gedeon Richter Plc Announce Positive Phase III ...4-traders (press release) all 9 news articles »

Henderson Sheriff's case highlights complex, sometimes devastating bipolar ... - Asheville Citizen-Times

Henderson Sheriff's case highlights complex, sometimes devastating bipolar ... Asheville Citizen-Times “You can have that presentation in middle-to-late life, when someone develops a manic episode, or a depression followed by mania,” Clark said. “You can have a very well-developed person who develops bipolar in their mid or late years, although it is ... and more »